Physician

Scott Allen Mcham, DO

According to 2025 Medicare claims, Scott Mcham, DO (NPI: 1235170473) practices hematology/oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is CANCER PARTNERS OF NEBRASKA PC (NPI: 1437111408; TIN: 911862785) and primary practice location at 68516-5587. Mcham is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Mcham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,121 traditional Medicare patients, billed 249,161 HCPCS/CPT codes, and received $4,006,880 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,089 prescription claims across 228 beneficiaries totaling $4,394,805 in drug costs, led by Revlimid (Lenalidomide). DME data shows 311 claims. Open Payments data shows 15 records totaling $771. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,279,836 to $4,006,880. Similarly, Part D prescription costs have moved sharply higher in recent years, from $334,295 to $4,394,805. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $14,156 to $25,803.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	321	164,818	$1,279,836
2016	461	304,022	$3,362,042
2017	575	242,894	$3,196,933
2018	680	228,090	$2,923,945
2019	855	222,396	$2,633,649
2020	928	233,811	$2,861,326
2021	1,024	235,249	$3,497,651
2022	993	195,581	$3,158,649
2023	1,050	253,251	$4,128,905
2024	1,121	249,161	$4,006,880

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	166	691	$334,295
2016	157	1,011	$599,908
2017	174	943	$690,465
2018	175	955	$1,261,652
2019	195	880	$1,366,047
2020	218	917	$1,510,070
2021	209	949	$2,028,302
2022	214	994	$3,535,620
2023	245	1,086	$2,862,990
2024	228	1,089	$4,394,805

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	245	$37,843
2016	11	249	$57,057
2017	14	262	$40,837
2018	11	217	$20,110
2019	17	137	$10,369
2020	13	92	$6,420
2021	34	141	$11,047
2022	14	122	$4,461
2023	65	314	$22,763
2024	145	311	$23,959

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	425	597	$57
80053	Blood test, comprehensive group of blood chemicals	755	1,634	$10
36415	Insertion of needle into vein for collection of blood sample	737	1,544	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	861	2,241	$8
83615	Lactate dehydrogenase (enzyme) level	390	839	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	73	2,044	$1,636,034
Lenalidomide	Lenalidomide	35	980	$535,095
Verzenio	Abemaciclib	19	532	$283,035
Pomalyst	Pomalidomide	12	336	$255,047
Imbruvica	Ibrutinib	16	448	$246,069

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8030	Breast prosthesis, silicone or equal, without integral adhesive	N	25	25	$7,990
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	58	83	$5,519
A6530	Gradient compression stocking, below knee, 18-30 mmhg, each	N	16	21	$1,995
L8020	Breast prosthesis, mastectomy form	N	11	11	$1,732
J8700	Temozolomide, oral, 5 mg	N	N/R	25	$1,327

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$267	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$505	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott Allen Mcham, DO?

Tedicare shows public-source Medicare data for Scott Allen Mcham, DO (NPI 1235170473), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Allen Mcham, DO have ACO affiliation data?

Scott Allen Mcham, DO is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Scott Allen Mcham, DO?

Scott Allen Mcham, DO is linked to CANCER PARTNERS OF NEBRASKA PC (billing NPI 1437111408) in the available physician profile data.

Does Scott Allen Mcham, DO have Open Payments data?

Scott Allen Mcham, DO has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.